72 related articles for article (PubMed ID: 33128780)
1. Chromosomal imbalances detected in NTRK-rearranged sarcomas by the use of comparative genomic hybridisation.
Vargas AC; Ardakani NM; Wong DD; Maclean FM; Kattampallil J; Boyle R; Santos L; Gill AJ
Histopathology; 2021 Jun; 78(7):932-942. PubMed ID: 33128780
[TBL] [Abstract][Full Text] [Related]
2. NTRK-rearranged spindle cell sarcoma of the uterine cervix with a novel NUMA1::NTRK1 fusion.
Szalai L; Vereczkey I; Szemes M; Rókusz A; Csernák E; Tóth E; Melegh Z
Virchows Arch; 2024 Mar; 484(3):527-531. PubMed ID: 38151535
[TBL] [Abstract][Full Text] [Related]
3. Elaboration of NTRK-rearranged colorectal cancer: Integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant.
Wu S; Liu Y; Shi X; Zhou W; Zeng X
Dig Liver Dis; 2023 Dec; 55(12):1757-1764. PubMed ID: 37142453
[TBL] [Abstract][Full Text] [Related]
4. Primary NTRK -rearranged Spindle Cell Neoplasm of the Gastrointestinal Tract: A Clinicopathological and Molecular Analysis of 8 Cases.
Gao X; Xu S; Zhu P; Lao IW; Yu L; Wang J
Am J Surg Pathol; 2024 May; 48(5):623-631. PubMed ID: 38525823
[TBL] [Abstract][Full Text] [Related]
5. Primary and Metastatic Melanoma With NTRK Fusions.
Lezcano C; Shoushtari AN; Ariyan C; Hollmann TJ; Busam KJ
Am J Surg Pathol; 2018 Aug; 42(8):1052-1058. PubMed ID: 29683819
[TBL] [Abstract][Full Text] [Related]
6. Acquired NF2 mutation confers resistance to TRK inhibition in an ex vivo LMNA::NTRK1-rearranged soft-tissue sarcoma cell model.
Chen Y; Steiner S; Hagedorn C; Kollar S; Pliego-Mendieta A; Haberecker M; Plock J; Britschgi C; Planas-Paz L; Pauli C
J Pathol; 2024 Jun; 263(2):257-269. PubMed ID: 38613194
[TBL] [Abstract][Full Text] [Related]
7. A recurrent NTRK1 tyrosine kinase domain mutation pair is characteristic in a subset of dedifferentiated liposarcomas.
Lippai Z; Péterfia B; Papp G; Dezső K; Bedics G; Pápai Z; Lamers MH; Kuin RC; Szuhai K; Sápi Z
Eur J Cancer; 2024 May; 202():114005. PubMed ID: 38531265
[TBL] [Abstract][Full Text] [Related]
8. [NTRK-rearranged uterine sarcoma: a clinicopathological analysis of seven cases].
Huang HJ; Wang C; Fan DG; He YH; Chen X; Zheng SL
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):189-191. PubMed ID: 38281791
[No Abstract] [Full Text] [Related]
9. Comprehensive clinicopathological, molecular, and methylation analysis of mesenchymal tumors with NTRK and other kinase gene aberrations.
Klubíčková N; Dermawan JK; Mosaieby E; Martínek P; Vaněček T; Hájková V; Ptáková N; Grossmann P; Šteiner P; Švajdler M; Kinkor Z; Michalová K; Szepe P; Plank L; Hederová S; Kolenová A; Spasov NJ; Kosemehmetoglu K; Pažanin L; Špůrková Z; Baník M; Baumruk L; Meyer A; Kalmykova A; Koshyk O; Michal M; Michal M
J Pathol; 2024 May; 263(1):61-73. PubMed ID: 38332737
[TBL] [Abstract][Full Text] [Related]
10. Estimating the Prognostic Value of the NTRK Fusion Biomarker for Comparative Effectiveness Research in The Netherlands.
Santi I; Vellekoop H; M Versteegh M; A Huygens S; Dinjens WNM; Mölken MR
Mol Diagn Ther; 2024 May; 28(3):319-328. PubMed ID: 38616205
[TBL] [Abstract][Full Text] [Related]
11. ETV6::NTRK3 gene fusion in a patient with metastatic lung atypical carcinoid successfully treated with repotrectinib: A case report.
Gao L; Ai X; Lu S
Lung Cancer; 2024 Jan; 187():107443. PubMed ID: 38113652
[TBL] [Abstract][Full Text] [Related]
12. Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience.
Orbach D; Mosseri V; Pissaloux D; Pierron G; Brennan B; Ferrari A; Chibon F; Bisogno G; De Salvo GL; Chakiba C; Corradini N; Minard-Colin V; Kelsey A; Ranchère-Vince D
Cancer Med; 2018 Apr; 7(4):1384-1393. PubMed ID: 29533008
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological features of NTRK-rearranged spindle cell neoplasms of the uterus of two cases].
Hu GM; Chen HP; Zhang RZ; Wu HF
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):480-482. PubMed ID: 38678330
[No Abstract] [Full Text] [Related]
14. Larotrectinib in a NTRK-rearranged soft tissue sarcoma in the neoadjuvant setting: A case report.
Percy C; Schubert T; Galant C; Kirchgesner T; Mazzeo F
Clin Case Rep; 2021 Mar; 9(3):1694-1698. PubMed ID: 33768917
[TBL] [Abstract][Full Text] [Related]
15. Distinct evolutionary mechanisms for genomic imbalances in high-risk and low-risk neuroblastomas.
Gisselsson D; Lundberg G; Ora I; Höglund M
J Carcinog; 2007 Sep; 6():15. PubMed ID: 17897457
[TBL] [Abstract][Full Text] [Related]
16. NTRK-rearranged spindle cell neoplasm: Initial observation of imaging appearance and clinicopathologic correlation.
Spano M; Davis-Hayes C; Hameed M; Benayed R; Hwang S
Clin Imaging; 2024 Mar; 110():110134. PubMed ID: 38631176
[TBL] [Abstract][Full Text] [Related]
17. A morphological mimic: An NTRK3-rearranged spindle cell neoplasm presenting as a groin mass.
Shelvey B; Dojcinov S; Roman M; Whitaker IS; Short E
J Cutan Pathol; 2024 Apr; ():. PubMed ID: 38661100
[TBL] [Abstract][Full Text] [Related]
18. [Ⅱ. Clinical Relevance of Comprehensive Genomic Profiling for Advanced Sarcomas].
Ogura K; Ikegami M; Kawai A
Gan To Kagaku Ryoho; 2024 Mar; 51(3):259-262. PubMed ID: 38494805
[No Abstract] [Full Text] [Related]
19. Transforming approaches to treating TRK fusion cancer: historical comparison of larotrectinib and histology-specific therapies.
Pollack M; Keating K; Wissinger E; Jackson L; Sarnes E; Cuffel B
Curr Med Res Opin; 2021 Jan; 37(1):59-70. PubMed ID: 33148054
[TBL] [Abstract][Full Text] [Related]
20. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives.
Sbaraglia M; Bellan E; Dei Tos AP
Pathologica; 2021 Apr; 113(2):70-84. PubMed ID: 33179614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
